Session Type
Meeting
Search Results for Support
Abstract Number: 371
SHM Converge 2024
Background: In-hospital patient deterioration, often unpredictable and multifaceted, presents a significant challenge in hospital medicine. Despite existing measures like illness severity scoring systems and rapid response teams (RRT), patient outcomes remain suboptimal. Delays in recognizing and treating worsening conditions lead to adverse effects and increased healthcare costs. Purpose: In our large healthcare system, covering two […]
Abstract Number: 375
Hospital Medicine 2020, Virtual Competition
Background: Time motion studies are often conducted to describe activities of physicians caring for hospitalized patients with the goal of improving efficiency and patient safety. Prior work has mostly focused on trainees at academic medical centers. However, with the growth of hospital systems, most academic hospitals now have a similar number of patients cared for […]
Abstract Number: 388
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Medical error is now the third leading cause of death in the United States. Approximately 4% of hospitalized patients experience an adverse event with 20% of these adverse events being medication-related, three-fourths of which are prescribing and administration errors. Vancomycin has been reported to account for one-fourth of the medication errors. Prescribing vancomycin is […]
Abstract Number: 408
SHM Converge 2024
Background: Care of hospitalized patients with Sickle Cell Disease (SCD) presents unique challenges due to variability in care, the interplay of acute and chronic pain, and the complex social determinants of health among patients with SCD. Despite comprising only a small percentage of admissions at our academic medical center, admissions for acute SCD-related illnesses have […]
Abstract Number: 423
Hospital Medicine 2020, Virtual Competition
Background: Acute Kidney Injury (AKI) is a common hospital problem which may lead to increased mortality, hospital costs, and increased length of stay (1). A leading cause of renal dysfunction in the inpatient population is drug nephrotoxicity. Several studies show that physician prescribers often do not take renal function into account with new or existing […]
Abstract Number: 764
SHM Converge 2021
Case Presentation: We present a 12-year-old female with paresthesia and swelling to the left lower extremity. She was seen in the outpatient setting two weeks prior and diagnosed with cellulitis. After only two days of antibiotics, she presented to the Emergency Department for worsening symptoms; she was noted to have a blue, cold, and swollen […]
Abstract Number: A12
SHM Converge 2022
Background: Long-term central venous access devices (CVADs) are integral to cancer care provision. Despite the high prevalence of CVAD occlusion in children with cancer, strategies to prevent occlusive events are understudied. We aimed to test the safety and feasibility of conducting a randomized controlled trial (RCT) comparing heparinised saline, with normal saline (0.9% sodium chloride) […]
Abstract Number: F17
SHM Converge 2022
Background: Hospital-at-Home (HaH) is a safe and effective alternative to high-cost, traditional hospitalization in patients with a range of medical conditions, such as non-severe community-acquired pneumonia (CAP). The COVID-19 pandemic created a unique situation with favorable policy changes, hospital resource constraints, and a clearly defined patient population that helped to increase HaH program deployment and […]
Abstract Number: H12
SHM Converge 2022
Background: While the electronic health record (EHR) provides many benefits, its use can easily allow for incomplete documentation of relevant historical information. The EHR is designed to store documentation of a patient’s past medical history (PMH), surgical history (PSH), family history (FH), and active hospital problems in the History tab. When the information is in […]
Abstract Number: O21
SHM Converge 2022
Background: Evidence-based guidelines/protocols for electrolyte replacement that safely encourage oral (PO) and/or intravenous (IV) dosing attain goal levels more successfully than standard care. PO is generally more comfortable and less dangerous than IV. Between 5/2017-11/2017, our institution dosed ~300,000 doses of potassium (K) and magnesium (Mg), with 30% and 19% of doses being PO, respectively. […]